D-1367-2020 Class III Terminated

Recalled by Rising Pharmaceuticals, Inc. — Saddle Brook, NJ

FDA drug recall D-1367-2020 was initiated by Rising Pharmaceuticals, Inc. on Nov 15, 2019 and is designated Class III. Reason for recall: Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside… The recall status is terminated (terminated Aug 22, 2022).

Recall details

Product Type
Drugs
Report Date
Jul 1, 2020
Initiation Date
Nov 15, 2019
Termination Date
Aug 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07663, Manufactured by: FDC Limited B-8, MIDC Industrial Area, Waluj, Aurangbad - 431 136 Marahastra, India, NDC 64980-514-05

Reason for recall

Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.

Distribution pattern

U.S.A. Nationwide

Code information

Lot # 089A016, Exp 12/31/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1367-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1367-2020. Report a data issue: hello@regdatalab.com.